Physician

Kayvan Kamali, M.D.

According to 2025 Medicare claims, Kayvan Kamali, M.D. (NPI: 1013912856) practices rheumatology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATION OF LONGVIEW, PLLC (NPI: 1205026432; TIN: 331080544) and primary practice location at 75601-5113. Kamali is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Kamali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 611 traditional Medicare patients, billed 32,533 HCPCS/CPT codes, and received $501,664 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 17,518 prescription claims across 1,394 beneficiaries totaling $9,374,630 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2015 DME data shows 11 claims. Open Payments data shows 211 records totaling $4,741. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $892,157 to $501,664. In contrast, Part D prescription costs have risen steadily, from $5,168,680 to $9,374,630. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.